Cargando…
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446011/ https://www.ncbi.nlm.nih.gov/pubmed/34531405 http://dx.doi.org/10.1038/s41467-021-25901-z |
_version_ | 1784568783693676544 |
---|---|
author | Alves, Carla L. Ehmsen, Sidse Terp, Mikkel G. Portman, Neil Tuttolomondo, Martina Gammelgaard, Odd L. Hundebøl, Monique F. Kaminska, Kamila Johansen, Lene E. Bak, Martin Honeth, Gabriella Bosch, Ana Lim, Elgene Ditzel, Henrik J. |
author_facet | Alves, Carla L. Ehmsen, Sidse Terp, Mikkel G. Portman, Neil Tuttolomondo, Martina Gammelgaard, Odd L. Hundebøl, Monique F. Kaminska, Kamila Johansen, Lene E. Bak, Martin Honeth, Gabriella Bosch, Ana Lim, Elgene Ditzel, Henrik J. |
author_sort | Alves, Carla L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8446011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84460112021-10-04 Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer Alves, Carla L. Ehmsen, Sidse Terp, Mikkel G. Portman, Neil Tuttolomondo, Martina Gammelgaard, Odd L. Hundebøl, Monique F. Kaminska, Kamila Johansen, Lene E. Bak, Martin Honeth, Gabriella Bosch, Ana Lim, Elgene Ditzel, Henrik J. Nat Commun Publisher Correction Nature Publishing Group UK 2021-09-16 /pmc/articles/PMC8446011/ /pubmed/34531405 http://dx.doi.org/10.1038/s41467-021-25901-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Publisher Correction Alves, Carla L. Ehmsen, Sidse Terp, Mikkel G. Portman, Neil Tuttolomondo, Martina Gammelgaard, Odd L. Hundebøl, Monique F. Kaminska, Kamila Johansen, Lene E. Bak, Martin Honeth, Gabriella Bosch, Ana Lim, Elgene Ditzel, Henrik J. Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer |
title | Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer |
title_full | Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer |
title_fullStr | Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer |
title_full_unstemmed | Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer |
title_short | Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer |
title_sort | publisher correction: co-targeting cdk4/6 and akt with endocrine therapy prevents progression in cdk4/6 inhibitor and endocrine therapy-resistant breast cancer |
topic | Publisher Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446011/ https://www.ncbi.nlm.nih.gov/pubmed/34531405 http://dx.doi.org/10.1038/s41467-021-25901-z |
work_keys_str_mv | AT alvescarlal publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT ehmsensidse publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT terpmikkelg publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT portmanneil publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT tuttolomondomartina publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT gammelgaardoddl publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT hundebølmoniquef publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT kaminskakamila publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT johansenlenee publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT bakmartin publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT honethgabriella publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT boschana publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT limelgene publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer AT ditzelhenrikj publishercorrectioncotargetingcdk46andaktwithendocrinetherapypreventsprogressionincdk46inhibitorandendocrinetherapyresistantbreastcancer |